Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
The hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It is now evident that miscellaneous diseases such as Diabetes, Autoimmune diseases, Ca...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.01017/full |
id |
doaj-24d49bab04cd4361a9afaef89ec093a6 |
---|---|
record_format |
Article |
spelling |
doaj-24d49bab04cd4361a9afaef89ec093a62020-11-24T21:06:14ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-01-011210.3389/fnins.2018.01017371025Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's DevelopmentZeba Mueed0Pallavi Tandon1Sanjeev Kumar Maurya2Ravi Deval3Mohammad A. Kamal4Mohammad A. Kamal5Mohammad A. Kamal6Nitesh Kumar Poddar7Department of Biotechnology, Invertis University, Bareilly, IndiaDepartment of Biotechnology, Invertis University, Bareilly, IndiaDepartment of Biotechnology, Invertis University, Bareilly, IndiaDepartment of Biotechnology, Invertis University, Bareilly, IndiaKing Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaEnzymoics, Hebersham, NSW, AustraliaNovel Global Community Educational Foundation, Hebersham, NSW, AustraliaDepartment of Biotechnology, Invertis University, Bareilly, IndiaThe hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It is now evident that miscellaneous diseases such as Diabetes, Autoimmune diseases, Cancer, etc. are correlated with AD. Therefore, we reviewed the literature on the causes of AD and investigated the association of tau and mTOR with other diseases. We have discussed the role of insulin deficiency in diabetes, activated microglial cells, and dysfunction of blood-brain barrier (BBB) in Autoimmune diseases, Presenilin 1 in skin cancer, increased reactive species in mitochondrial dysfunction and deregulated Cyclins/CDKs in promoting AD pathogenesis. We have also discussed the possible therapeutics for AD such as GSK3 inactivation therapy, Rechaperoning therapy, Immunotherapy, Hormonal therapy, Metal chelators, Cell cycle therapy, γ-secretase modulators, and Cholinesterase and BACE 1-inhibitors which are thought to serve a major role in combating pathological changes coupled with AD. Recent research about the relationship between mTOR and aging and hepatic Aβ degradation offers possible targets to effectively target AD. Future prospects of AD aims at developing novel drugs and modulators that can potentially improve cell to cell signaling, prevent Aβ plaques formation, promote better release of neurotransmitters and prevent hyperphosphorylation of tau.https://www.frontiersin.org/article/10.3389/fnins.2018.01017/fullAlzheimer's disease (AD)taumTORAβ plaquesAβ modulatorshyperphosphorylation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zeba Mueed Pallavi Tandon Sanjeev Kumar Maurya Ravi Deval Mohammad A. Kamal Mohammad A. Kamal Mohammad A. Kamal Nitesh Kumar Poddar |
spellingShingle |
Zeba Mueed Pallavi Tandon Sanjeev Kumar Maurya Ravi Deval Mohammad A. Kamal Mohammad A. Kamal Mohammad A. Kamal Nitesh Kumar Poddar Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development Frontiers in Neuroscience Alzheimer's disease (AD) tau mTOR Aβ plaques Aβ modulators hyperphosphorylation |
author_facet |
Zeba Mueed Pallavi Tandon Sanjeev Kumar Maurya Ravi Deval Mohammad A. Kamal Mohammad A. Kamal Mohammad A. Kamal Nitesh Kumar Poddar |
author_sort |
Zeba Mueed |
title |
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development |
title_short |
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development |
title_full |
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development |
title_fullStr |
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development |
title_full_unstemmed |
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development |
title_sort |
tau and mtor: the hotspots for multifarious diseases in alzheimer's development |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroscience |
issn |
1662-453X |
publishDate |
2019-01-01 |
description |
The hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It is now evident that miscellaneous diseases such as Diabetes, Autoimmune diseases, Cancer, etc. are correlated with AD. Therefore, we reviewed the literature on the causes of AD and investigated the association of tau and mTOR with other diseases. We have discussed the role of insulin deficiency in diabetes, activated microglial cells, and dysfunction of blood-brain barrier (BBB) in Autoimmune diseases, Presenilin 1 in skin cancer, increased reactive species in mitochondrial dysfunction and deregulated Cyclins/CDKs in promoting AD pathogenesis. We have also discussed the possible therapeutics for AD such as GSK3 inactivation therapy, Rechaperoning therapy, Immunotherapy, Hormonal therapy, Metal chelators, Cell cycle therapy, γ-secretase modulators, and Cholinesterase and BACE 1-inhibitors which are thought to serve a major role in combating pathological changes coupled with AD. Recent research about the relationship between mTOR and aging and hepatic Aβ degradation offers possible targets to effectively target AD. Future prospects of AD aims at developing novel drugs and modulators that can potentially improve cell to cell signaling, prevent Aβ plaques formation, promote better release of neurotransmitters and prevent hyperphosphorylation of tau. |
topic |
Alzheimer's disease (AD) tau mTOR Aβ plaques Aβ modulators hyperphosphorylation |
url |
https://www.frontiersin.org/article/10.3389/fnins.2018.01017/full |
work_keys_str_mv |
AT zebamueed tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT pallavitandon tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT sanjeevkumarmaurya tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT ravideval tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT mohammadakamal tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT mohammadakamal tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT mohammadakamal tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment AT niteshkumarpoddar tauandmtorthehotspotsformultifariousdiseasesinalzheimersdevelopment |
_version_ |
1716766266846347264 |